| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Secreting Cells | 31 | 2024 | 404 | 3.640 |
Why?
|
| Diabetes Mellitus, Type 1 | 23 | 2024 | 559 | 3.060 |
Why?
|
| Islets of Langerhans | 16 | 2022 | 548 | 2.030 |
Why?
|
| Arachidonate 12-Lipoxygenase | 8 | 2021 | 23 | 1.800 |
Why?
|
| Diabetes Mellitus, Experimental | 7 | 2022 | 191 | 1.350 |
Why?
|
| Cell Death | 5 | 2021 | 262 | 1.310 |
Why?
|
| Insulin | 15 | 2021 | 1146 | 1.240 |
Why?
|
| DNA Methylation | 8 | 2021 | 657 | 1.030 |
Why?
|
| Arachidonate 15-Lipoxygenase | 6 | 2021 | 15 | 1.030 |
Why?
|
| DNA | 6 | 2018 | 1307 | 0.890 |
Why?
|
| Diet, High-Fat | 7 | 2021 | 117 | 0.770 |
Why?
|
| Mice | 42 | 2024 | 11742 | 0.710 |
Why?
|
| Protein Precursors | 3 | 2018 | 140 | 0.700 |
Why?
|
| Polyamines | 3 | 2024 | 37 | 0.660 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2362 | 0.620 |
Why?
|
| Obesity | 5 | 2021 | 966 | 0.620 |
Why?
|
| Oxidative Stress | 5 | 2022 | 458 | 0.620 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 5 | 2021 | 19 | 0.610 |
Why?
|
| Insulin Resistance | 7 | 2022 | 353 | 0.600 |
Why?
|
| Mice, Inbred NOD | 13 | 2024 | 195 | 0.560 |
Why?
|
| Animals | 48 | 2024 | 27324 | 0.560 |
Why?
|
| Biomarkers | 6 | 2021 | 1755 | 0.530 |
Why?
|
| Peptide Initiation Factors | 6 | 2019 | 27 | 0.520 |
Why?
|
| Endoplasmic Reticulum | 3 | 2012 | 255 | 0.510 |
Why?
|
| Cell-Free Nucleic Acids | 3 | 2021 | 83 | 0.500 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2022 | 1176 | 0.480 |
Why?
|
| Islets of Langerhans Transplantation | 4 | 2020 | 241 | 0.460 |
Why?
|
| Lysine | 4 | 2019 | 150 | 0.450 |
Why?
|
| RNA-Binding Proteins | 6 | 2019 | 258 | 0.430 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 738 | 0.410 |
Why?
|
| Unfolded Protein Response | 4 | 2024 | 43 | 0.400 |
Why?
|
| Mice, Knockout | 11 | 2021 | 1990 | 0.400 |
Why?
|
| Stress, Physiological | 1 | 2012 | 229 | 0.360 |
Why?
|
| Dietary Fats | 3 | 2020 | 135 | 0.340 |
Why?
|
| Pancreas | 3 | 2022 | 244 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 3211 | 0.320 |
Why?
|
| Macrophages | 3 | 2023 | 571 | 0.300 |
Why?
|
| Trans-Activators | 4 | 2017 | 443 | 0.300 |
Why?
|
| Glucose | 3 | 2019 | 630 | 0.290 |
Why?
|
| Homeodomain Proteins | 4 | 2017 | 556 | 0.270 |
Why?
|
| Protein Biosynthesis | 3 | 2017 | 388 | 0.250 |
Why?
|
| Glucose Intolerance | 3 | 2014 | 94 | 0.240 |
Why?
|
| Apoptosis | 3 | 2020 | 1717 | 0.240 |
Why?
|
| eIF-2 Kinase | 1 | 2024 | 48 | 0.240 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2023 | 6 | 0.230 |
Why?
|
| Eflornithine | 3 | 2024 | 14 | 0.230 |
Why?
|
| Endoplasmic Reticulum Stress | 3 | 2022 | 85 | 0.230 |
Why?
|
| Zebrafish Proteins | 2 | 2021 | 149 | 0.220 |
Why?
|
| PPAR gamma | 2 | 2016 | 73 | 0.210 |
Why?
|
| Inflammation | 4 | 2023 | 971 | 0.210 |
Why?
|
| Cytokines | 3 | 2024 | 802 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2019 | 2011 | 0.200 |
Why?
|
| Male | 19 | 2022 | 42254 | 0.200 |
Why?
|
| Female | 18 | 2022 | 46014 | 0.200 |
Why?
|
| Receptors, CXCR3 | 1 | 2021 | 12 | 0.200 |
Why?
|
| Blood Glucose | 6 | 2020 | 836 | 0.200 |
Why?
|
| Creatine | 1 | 2021 | 25 | 0.190 |
Why?
|
| Naphthalenes | 2 | 2019 | 45 | 0.190 |
Why?
|
| Lipoxygenases | 1 | 2020 | 3 | 0.190 |
Why?
|
| Isoxazoles | 2 | 2019 | 77 | 0.190 |
Why?
|
| Signal Transduction | 5 | 2020 | 3374 | 0.180 |
Why?
|
| Organogenesis | 1 | 2020 | 50 | 0.180 |
Why?
|
| Growth Differentiation Factor 15 | 1 | 2020 | 8 | 0.180 |
Why?
|
| Pediatric Obesity | 1 | 2020 | 25 | 0.180 |
Why?
|
| Cell Communication | 1 | 2021 | 199 | 0.180 |
Why?
|
| Cell Movement | 1 | 2023 | 783 | 0.180 |
Why?
|
| Adipose Tissue, White | 1 | 2019 | 23 | 0.170 |
Why?
|
| Adipogenesis | 1 | 2019 | 39 | 0.170 |
Why?
|
| Humans | 27 | 2024 | 89073 | 0.170 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 128 | 0.170 |
Why?
|
| Intravital Microscopy | 1 | 2019 | 11 | 0.170 |
Why?
|
| Thermogenesis | 1 | 2019 | 41 | 0.170 |
Why?
|
| Adipose Tissue, Brown | 1 | 2019 | 86 | 0.170 |
Why?
|
| Aging | 2 | 2016 | 716 | 0.170 |
Why?
|
| Models, Biological | 2 | 2017 | 1764 | 0.160 |
Why?
|
| Glutamate Decarboxylase | 1 | 2019 | 32 | 0.160 |
Why?
|
| Calcium Channels, R-Type | 1 | 2018 | 4 | 0.160 |
Why?
|
| Collagen | 1 | 2020 | 293 | 0.160 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1975 | 0.160 |
Why?
|
| Tissue Survival | 1 | 2018 | 13 | 0.160 |
Why?
|
| rho-Associated Kinases | 1 | 2019 | 160 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2020 | 324 | 0.160 |
Why?
|
| Zebrafish | 4 | 2023 | 319 | 0.160 |
Why?
|
| Collagen Type I | 1 | 2018 | 72 | 0.150 |
Why?
|
| Streptozocin | 2 | 2019 | 55 | 0.150 |
Why?
|
| Graft Survival | 2 | 2020 | 898 | 0.150 |
Why?
|
| Hydroxyquinolines | 1 | 2017 | 4 | 0.150 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 2017 | 33 | 0.150 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2019 | 217 | 0.150 |
Why?
|
| Thiophenes | 1 | 2017 | 43 | 0.150 |
Why?
|
| Calcitriol | 1 | 2018 | 173 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2018 | 130 | 0.150 |
Why?
|
| Energy Metabolism | 2 | 2019 | 277 | 0.140 |
Why?
|
| Calcium | 2 | 2018 | 1172 | 0.140 |
Why?
|
| Thiazolidinediones | 1 | 2016 | 73 | 0.140 |
Why?
|
| Mice, Inbred Strains | 2 | 2013 | 308 | 0.140 |
Why?
|
| Endothelial Cells | 1 | 2019 | 459 | 0.130 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 529 | 0.130 |
Why?
|
| Nuclear Proteins | 1 | 2020 | 726 | 0.130 |
Why?
|
| Sirtuins | 1 | 2016 | 46 | 0.130 |
Why?
|
| Transcription Factors | 2 | 2021 | 1652 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2013 | 261 | 0.130 |
Why?
|
| DNA Damage | 1 | 2017 | 371 | 0.130 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 490 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 289 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 887 | 0.120 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 24 | 0.120 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 65 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 412 | 0.120 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2014 | 48 | 0.120 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 43 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 173 | 0.120 |
Why?
|
| Hyperplasia | 1 | 2014 | 152 | 0.120 |
Why?
|
| Liver | 2 | 2017 | 1205 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 161 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2019 | 551 | 0.110 |
Why?
|
| DNA Repair | 1 | 2016 | 362 | 0.110 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2013 | 9 | 0.110 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2013 | 78 | 0.110 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2013 | 35 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 177 | 0.110 |
Why?
|
| Adipose Tissue | 3 | 2021 | 259 | 0.110 |
Why?
|
| Oxygenases | 1 | 2013 | 13 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 51 | 0.110 |
Why?
|
| Graft Rejection | 1 | 2019 | 1067 | 0.110 |
Why?
|
| Necrosis | 1 | 2013 | 209 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2019 | 342 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2013 | 166 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 92 | 0.110 |
Why?
|
| Cytological Techniques | 1 | 2012 | 30 | 0.110 |
Why?
|
| Triazoles | 1 | 2013 | 102 | 0.110 |
Why?
|
| Collagenases | 1 | 2012 | 41 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2024 | 2412 | 0.100 |
Why?
|
| Ornithine Decarboxylase | 2 | 2023 | 9 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 282 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2012 | 117 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2019 | 1650 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1265 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1521 | 0.100 |
Why?
|
| Genomics | 1 | 2017 | 761 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2021 | 2553 | 0.100 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 65 | 0.090 |
Why?
|
| Phenotype | 2 | 2021 | 2439 | 0.090 |
Why?
|
| Primary Cell Culture | 2 | 2021 | 76 | 0.090 |
Why?
|
| Cell Survival | 3 | 2020 | 982 | 0.090 |
Why?
|
| Euchromatin | 1 | 2009 | 6 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1940 | 0.080 |
Why?
|
| Diabetes Complications | 1 | 2010 | 170 | 0.080 |
Why?
|
| Manganese | 1 | 2008 | 55 | 0.080 |
Why?
|
| Autophagy | 2 | 2022 | 159 | 0.080 |
Why?
|
| Crosses, Genetic | 2 | 2019 | 171 | 0.080 |
Why?
|
| Interleukin-1beta | 2 | 2020 | 82 | 0.070 |
Why?
|
| Weight Gain | 2 | 2020 | 119 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 3000 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2880 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2020 | 451 | 0.060 |
Why?
|
| Lymph Nodes | 2 | 2022 | 548 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1875 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2018 | 638 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2024 | 17 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2023 | 14 | 0.060 |
Why?
|
| Spermine | 1 | 2024 | 24 | 0.060 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 2023 | 3 | 0.060 |
Why?
|
| Putrescine | 1 | 2023 | 6 | 0.060 |
Why?
|
| Cell Line | 2 | 2020 | 2495 | 0.060 |
Why?
|
| Middle Aged | 5 | 2020 | 25865 | 0.060 |
Why?
|
| Pancreatic Hormones | 1 | 2022 | 15 | 0.050 |
Why?
|
| Adult | 5 | 2020 | 26508 | 0.050 |
Why?
|
| Glucose Tolerance Test | 2 | 2016 | 227 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 1487 | 0.050 |
Why?
|
| Neoplasms | 1 | 2017 | 3035 | 0.050 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2021 | 13 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2017 | 755 | 0.050 |
Why?
|
| Amidinotransferases | 1 | 2021 | 5 | 0.050 |
Why?
|
| Coenzyme A Ligases | 1 | 2021 | 8 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2017 | 727 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2021 | 183 | 0.050 |
Why?
|
| Diet, Fat-Restricted | 1 | 2020 | 30 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2020 | 63 | 0.050 |
Why?
|
| Diet, Western | 1 | 2020 | 38 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 306 | 0.050 |
Why?
|
| Parathyroid Hormone | 1 | 2021 | 216 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 101 | 0.040 |
Why?
|
| Laboratory Proficiency Testing | 1 | 2020 | 5 | 0.040 |
Why?
|
| Injections, Subcutaneous | 1 | 2020 | 125 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 273 | 0.040 |
Why?
|
| Cyclin D2 | 1 | 2019 | 19 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 102 | 0.040 |
Why?
|
| Biological Assay | 1 | 2020 | 79 | 0.040 |
Why?
|
| RNA Interference | 1 | 2021 | 376 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2021 | 169 | 0.040 |
Why?
|
| Allografts | 1 | 2020 | 181 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2019 | 126 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 557 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2019 | 268 | 0.040 |
Why?
|
| Fibrillar Collagens | 1 | 2018 | 10 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2018 | 91 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 138 | 0.040 |
Why?
|
| Polymerization | 1 | 2018 | 32 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2019 | 73 | 0.040 |
Why?
|
| Dermis | 1 | 2018 | 28 | 0.040 |
Why?
|
| C-Peptide | 1 | 2018 | 179 | 0.040 |
Why?
|
| Proteomics | 1 | 2020 | 230 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2019 | 301 | 0.040 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2021 | 429 | 0.040 |
Why?
|
| Homeostasis | 1 | 2019 | 413 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 277 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 1237 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2018 | 103 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 459 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 87 | 0.040 |
Why?
|
| Young Adult | 2 | 2020 | 6289 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2016 | 16 | 0.040 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2016 | 15 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2017 | 289 | 0.030 |
Why?
|
| Swine | 1 | 2018 | 581 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 996 | 0.030 |
Why?
|
| Child | 2 | 2020 | 7149 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 3443 | 0.030 |
Why?
|
| Fatty Acids, Volatile | 1 | 2016 | 32 | 0.030 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 68 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2017 | 298 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 1135 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 1057 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 183 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 510 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2017 | 779 | 0.030 |
Why?
|
| Glycolysis | 1 | 2016 | 135 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2016 | 243 | 0.030 |
Why?
|
| Polyribosomes | 1 | 2014 | 20 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2015 | 110 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 308 | 0.030 |
Why?
|
| 5' Untranslated Regions | 1 | 2014 | 51 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 273 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 104 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 268 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 36 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 481 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1855 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 4041 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2013 | 32 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 1182 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1710 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 2752 | 0.030 |
Why?
|
| Adiposity | 1 | 2013 | 76 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 688 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 507 | 0.030 |
Why?
|
| Software | 1 | 2017 | 665 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2013 | 105 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2013 | 84 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 89 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2017 | 1097 | 0.030 |
Why?
|
| Guanine | 1 | 2013 | 207 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 200 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 306 | 0.030 |
Why?
|
| Aged | 2 | 2020 | 19078 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2013 | 109 | 0.030 |
Why?
|
| Mitochondria | 1 | 2016 | 553 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 3657 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 783 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 2062 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 87 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2010 | 14 | 0.020 |
Why?
|
| Prognosis | 1 | 2019 | 3773 | 0.020 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2010 | 10 | 0.020 |
Why?
|
| Thapsigargin | 1 | 2010 | 55 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 699 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 2863 | 0.020 |
Why?
|
| Oxygen | 1 | 2016 | 742 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 162 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2010 | 231 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3027 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1157 | 0.020 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2009 | 24 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 55 | 0.020 |
Why?
|
| Protein Transport | 1 | 2010 | 421 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 3717 | 0.020 |
Why?
|
| Glycosuria | 1 | 2007 | 4 | 0.020 |
Why?
|
| Tail | 1 | 2007 | 31 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2007 | 49 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 645 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2007 | 205 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 543 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 4132 | 0.020 |
Why?
|
| Genome | 1 | 2007 | 386 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 1076 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 9237 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 2335 | 0.010 |
Why?
|